Zacks Research Analysts Decrease Earnings Estimates for DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) – Equities research analysts at Zacks Research dropped their Q2 2024 earnings per share (EPS) estimates for shares of DENTSPLY SIRONA in a research note issued on Tuesday, July 23rd. Zacks Research analyst I. Bandyopadhyay now anticipates that the medical instruments supplier will post earnings per share of $0.50 for the quarter, down from their previous estimate of $0.51. The consensus estimate for DENTSPLY SIRONA’s current full-year earnings is $2.02 per share. Zacks Research also issued estimates for DENTSPLY SIRONA’s Q3 2024 earnings at $0.51 EPS, FY2024 earnings at $2.00 EPS, FY2025 earnings at $2.33 EPS and FY2026 earnings at $2.57 EPS.

A number of other research firms also recently commented on XRAY. Evercore ISI decreased their price objective on shares of DENTSPLY SIRONA from $28.00 to $27.00 and set an “outperform” rating on the stock in a report on Tuesday, July 9th. Stifel Nicolaus lowered their price target on DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating on the stock in a report on Thursday, July 18th. Barrington Research reaffirmed an “outperform” rating and set a $38.00 price objective on shares of DENTSPLY SIRONA in a report on Monday, July 8th. StockNews.com lowered DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Friday, May 3rd. Finally, Piper Sandler reaffirmed a “neutral” rating and set a $32.00 price target (down previously from $35.00) on shares of DENTSPLY SIRONA in a research note on Friday, May 3rd. Five investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat.com, DENTSPLY SIRONA has a consensus rating of “Moderate Buy” and an average target price of $33.67.

DENTSPLY SIRONA Stock Up 0.7 %

XRAY opened at $26.43 on Wednesday. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.43 and a quick ratio of 0.97. DENTSPLY SIRONA has a 12 month low of $23.94 and a 12 month high of $41.65. The stock has a market capitalization of $5.49 billion, a P/E ratio of -60.07, a P/E/G ratio of 1.17 and a beta of 1.01. The business has a 50 day simple moving average of $26.39 and a 200-day simple moving average of $30.52.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Thursday, May 2nd. The medical instruments supplier reported $0.42 EPS for the quarter, meeting analysts’ consensus estimates of $0.42. DENTSPLY SIRONA had a negative net margin of 2.41% and a positive return on equity of 11.54%. The firm had revenue of $953.00 million during the quarter, compared to the consensus estimate of $969.45 million. During the same quarter last year, the firm earned $0.39 earnings per share. The firm’s revenue was down 2.6% compared to the same quarter last year.

Hedge Funds Weigh In On DENTSPLY SIRONA

Institutional investors have recently added to or reduced their stakes in the business. Mitsubishi UFJ Asset Management Co. Ltd. grew its holdings in DENTSPLY SIRONA by 44.2% in the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 141,117 shares of the medical instruments supplier’s stock valued at $4,684,000 after buying an additional 43,230 shares during the period. Seven Eight Capital LP purchased a new stake in DENTSPLY SIRONA in the first quarter valued at approximately $1,409,000. Illinois Municipal Retirement Fund increased its position in DENTSPLY SIRONA by 369.9% during the first quarter. Illinois Municipal Retirement Fund now owns 123,580 shares of the medical instruments supplier’s stock worth $4,102,000 after purchasing an additional 97,281 shares during the last quarter. Intech Investment Management LLC purchased a new position in DENTSPLY SIRONA during the first quarter worth approximately $1,202,000. Finally, Duality Advisers LP acquired a new position in shares of DENTSPLY SIRONA in the 1st quarter valued at $1,166,000. 95.70% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, Director Gregory T. Lucier acquired 3,577 shares of DENTSPLY SIRONA stock in a transaction that occurred on Friday, May 31st. The shares were acquired at an average price of $27.95 per share, with a total value of $99,977.15. Following the completion of the purchase, the director now owns 58,374 shares of the company’s stock, valued at approximately $1,631,553.30. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 0.52% of the stock is owned by corporate insiders.

DENTSPLY SIRONA Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, July 12th. Shareholders of record on Friday, June 28th were issued a $0.16 dividend. The ex-dividend date was Friday, June 28th. This represents a $0.64 dividend on an annualized basis and a yield of 2.42%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -145.45%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.